Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | UACA | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | TGFBRAP1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | PACS2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | GLUD2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | FOSL1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | GRAMD4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | SLC25A43 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | THEM4 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
mRNA | PHLPP2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | CEBPG | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |